Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ullrich

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Psychopharmacology|March 15, 2005
Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamineDavid V Herin, Shijing Liu, Thomas Ullrich, et al.
Journal of Medicinal Chemistry|August 23, 2002
Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptorThomas Ullrich, Sylvia Krich, Dieter Binder, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chainThomas Ullrich, Karl Baumann, Karl Welzenbach, et al.
Psychopharmacology|July 3, 2008
Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learningCatherine M Davis, Glenn W Stevenson, Fernando Cañadas, et al.
Biomedical Chromatography : BMC|September 21, 2010
Chiral separation of the β2-sympathomimetic fenoterol by HPLC and capillary zone electrophoresis for pharmacokinetic studiesThomas Ullrich, Dirk Wesenberg, Corinna Bleuel, et al.
Pharmacology, Biochemistry, and Behavior|January 29, 2002
Delta opioid discrimination learning in the rat: assessment with the selective delta agonist SNC80Glenn W Stevenson, Fernando Cañadas, Maria Gomez-Serrano, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressivaThomas Ullrich, Luca Arista, Sven Weiler, et al.
Psychopharmacology|February 4, 2003
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded miceWilliam E Fantegrossi, Tomek Godlewski, Rachel L Karabenick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2018
Developmentally inspired programming of adult human mesenchymal stromal cells toward stable chondrogenesisPaola Occhetta, Sebastien Pigeot, Marco Rasponi, et al.
Expert Opinion on Drug Delivery|July 25, 2022
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunitiesCéline Bassand, Alessia Villois, Lucas Gianola, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Psychopharmacology|March 15, 2005
Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamineDavid V Herin, Shijing Liu, Thomas Ullrich, et al.
Journal of Medicinal Chemistry|August 23, 2002
Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptorThomas Ullrich, Sylvia Krich, Dieter Binder, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chainThomas Ullrich, Karl Baumann, Karl Welzenbach, et al.
Psychopharmacology|July 3, 2008
Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learningCatherine M Davis, Glenn W Stevenson, Fernando Cañadas, et al.
Biomedical Chromatography : BMC|September 21, 2010
Chiral separation of the β2-sympathomimetic fenoterol by HPLC and capillary zone electrophoresis for pharmacokinetic studiesThomas Ullrich, Dirk Wesenberg, Corinna Bleuel, et al.
Pharmacology, Biochemistry, and Behavior|January 29, 2002
Delta opioid discrimination learning in the rat: assessment with the selective delta agonist SNC80Glenn W Stevenson, Fernando Cañadas, Maria Gomez-Serrano, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressivaThomas Ullrich, Luca Arista, Sven Weiler, et al.
Psychopharmacology|February 4, 2003
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded miceWilliam E Fantegrossi, Tomek Godlewski, Rachel L Karabenick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2018
Developmentally inspired programming of adult human mesenchymal stromal cells toward stable chondrogenesisPaola Occhetta, Sebastien Pigeot, Marco Rasponi, et al.
Expert Opinion on Drug Delivery|July 25, 2022
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunitiesCéline Bassand, Alessia Villois, Lucas Gianola, et al.
Pageof 3